Inge Christoffer Olsen Selected Research

Hypersensitivity (Allergy)

1/2020

Skin emollient and early complementary feeding to prevent infant atopic dermatitis (PreventADALL): a factorial, multicentre, cluster-randomised trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Inge Christoffer Olsen Research Topics

Disease

11	Rheumatoid Arthritis 10/2023 - 02/2015
5	COVID-19 01/2023 - 06/2020
3	Psoriasis (Pustulosis Palmaris et Plantaris) 12/2021 - 06/2020
3	Inflammation (Inflammations) 11/2021 - 12/2017
3	Rheumatic Diseases (Rheumatism) 12/2017 - 08/2016
2	Respiratory Insufficiency (Respiratory Failure) 01/2022 - 01/2021
2	Necrosis 01/2022 - 02/2015
2	Food Hypersensitivity (Food Allergy) 01/2022 - 01/2020
2	Crohn Disease (Crohn's Disease) 12/2021 - 01/2021
2	Psoriatic Arthritis 12/2021 - 01/2021
2	Ulcerative Colitis 12/2021 - 01/2021
2	Joint Diseases (Joint Disease) 02/2015 - 02/2014
1	Fibrosis (Cirrhosis) 11/2023
1	Chronic Obstructive Pulmonary Disease (COPD) 12/2021
1	Tuberculosis (Tuberculoses) 11/2021
1	Exanthema (Rash) 11/2021
1	Disease Progression 11/2021
1	Extrapulmonary Tuberculosis 11/2021
1	Asthma (Bronchial Asthma) 01/2020
1	Atopic Dermatitis (Atopic Eczema) 01/2020
1	Hypersensitivity (Allergy) 01/2020
1	Dystocia 01/2019
1	Pyelonephritis 01/2018
1	Urinary Tract Infections (Urinary Tract Infection) 01/2018
1	Pain (Aches) 01/2016
1	Fatigue 01/2016
1	Synovitis 02/2014
1	Multiple Sclerosis 08/2012
1	Relapsing-Remitting Multiple Sclerosis 06/2009

Drug/Important Bio-Agent (IBA)

6	Antirheumatic Agents (DMARD)IBA 11/2021 - 02/2015
4	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 12/2021 - 06/2020
3	remdesivirIBA 01/2023 - 01/2021
3	Infliximab (Remicade)FDA Link 01/2022 - 01/2021
2	EmollientsIBA 01/2022 - 01/2020
2	AntibodiesIBA 01/2022 - 01/2021
2	Interferon beta-1a FDA Link 08/2012 - 06/2009
1	RNA (Ribonucleic Acid)IBA 11/2023
1	Abatacept (Orencia)FDA Link 10/2023
1	Certolizumab Pegol FDA Link 10/2023
1	tocilizumab (atlizumab)FDA Link 10/2023
1	Oxygen (Dioxygen)IBA 01/2023
1	lipopolysaccharide-binding proteinIBA 01/2022
1	Tumor Necrosis Factor InhibitorsIBA 01/2022
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 12/2021
1	VaccinesIBA 11/2021
1	EtoricoxibIBA 11/2021
1	Antiviral Agents (Antivirals)IBA 01/2021
1	Oxytocin (Pitocin)FDA LinkGeneric 01/2019
1	Ibuprofen (Motrin)FDA LinkGeneric 01/2018
1	Amdinocillin Pivoxil (Pivmecillinam)IBA 01/2018
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2018
1	Leukocyte L1 Antigen Complex (Calgranulin)IBA 12/2017
1	ametantrone (HAQ)IBA 01/2016
1	Methotrexate (Mexate)FDA LinkGeneric 02/2015
1	Rheumatoid FactorIBA 02/2014
1	C-Reactive ProteinIBA 02/2014
1	Fatty Acids (Saturated Fatty Acids)IBA 08/2012
1	Methylprednisolone FDA LinkGeneric 06/2009
1	Interferon-betaIBA 06/2009

Therapy/Procedure

8	Therapeutics 12/2021 - 06/2009
1	Drug Therapy (Chemotherapy) 08/2016